FDA
approval
· 2016-12-06
FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for IRBESARTAN filed by Camber Pharmaceuticals, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN (IRBESARTAN)